These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 36177738

  • 1. Ivermectin treatment in rosacea: How novel smartphone technology can support monitoring rosacea-associated signs and symptoms.
    Schaller M, Riel S, Bashur R, Kurup N, Schnidar H, Fehrenbacher B.
    Dermatol Ther; 2022 Nov; 35(11):e15869. PubMed ID: 36177738
    [Abstract] [Full Text] [Related]

  • 2. Fabrication and efficacy assessment of combination of brimonidine and ivermectin for treatment of papulopustular rosacea.
    Pakdaman SF, Samadi A, Fattahi M, Naeimifar A, Ardehali FA, Ketabi Y, Nasrollahi SA, Firooz A.
    J Cosmet Dermatol; 2024 Sep; 23(9):2973-2981. PubMed ID: 38831548
    [Abstract] [Full Text] [Related]

  • 3. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea.
    Schaller M, Gonser L, Belge K, Braunsdorf C, Nordin R, Scheu A, Borelli C.
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1907-1911. PubMed ID: 28653460
    [Abstract] [Full Text] [Related]

  • 4. Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol.
    Huang HP, Hsu CK, Lee JY.
    Dermatol Ther; 2021 Mar; 34(2):e14899. PubMed ID: 33605018
    [Abstract] [Full Text] [Related]

  • 5. A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.
    Schaller M, Kemény L, Havlickova B, Jackson JM, Ambroziak M, Lynde C, Gooderham M, Remenyik E, Del Rosso J, Weglowska J, Chavda R, Kerrouche N, Dirschka T, Johnson S.
    J Am Acad Dermatol; 2020 Feb; 82(2):336-343. PubMed ID: 31150711
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Erythema-directed digital photography and colorimeter scores correlate with rosacea erythema evaluation in patients under treatment with topical ivermectin.
    Dall'Oglio F, Lacarrubba F, Micali G.
    Dermatol Ther; 2021 May; 34(3):e14920. PubMed ID: 33641260
    [Abstract] [Full Text] [Related]

  • 8. Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study.
    Eichenfield LF, Del Rosso JQ, Tan JKL, Hebert AA, Webster GF, Harper J, Baldwin HE, Kircik LH, Stein-Gold L, Kaoukhov A, Alvandi N.
    Br J Dermatol; 2019 May; 180(5):1050-1057. PubMed ID: 30500065
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety results of micellar water, cream and serum for rosacea in comparison to a control group.
    Guertler A, Jøntvedt NM, Clanner-Engelshofen BM, Cappello C, Sager A, Reinholz M.
    J Cosmet Dermatol; 2020 Oct; 19(10):2627-2633. PubMed ID: 32623833
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ivermectin: A Review in Rosacea.
    Deeks ED.
    Am J Clin Dermatol; 2015 Oct; 16(5):447-52. PubMed ID: 26254001
    [Abstract] [Full Text] [Related]

  • 12. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
    Baumann L, Goldberg DJ, Stein Gold L, Tanghetti EA, Lain E, Kaufman J, Weng E, Berk DR, Ahluwalia G.
    J Drugs Dermatol; 2018 Mar 01; 17(3):290-298. PubMed ID: 29537447
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Benefits and safety of Oxymetazoline cream 1% on rosacea-associated erythema: A systematic review and analysis of clinical evidence.
    Yuan X, Yin D.
    J Cosmet Dermatol; 2023 Jan 01; 22(1):103-110. PubMed ID: 36237138
    [Abstract] [Full Text] [Related]

  • 16. Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.
    Tanghetti EA, Dover JS, Goldberg DJ, Dhawan SS, Luo L, Berk DR, Ahluwalia G, Alvandi N.
    J Drugs Dermatol; 2018 Jun 01; 17(6):621-626. PubMed ID: 29879249
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Facial Dermatitis and Rosacea.
    Fowler JF.
    Semin Cutan Med Surg; 2016 Jun 01; 35(6 Suppl):S107-9. PubMed ID: 27537212
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.